Skip to main content
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1995 Oct;79(10):905–909. doi: 10.1136/bjo.79.10.905

Effects of argon (green) laser treatment of soft drusen in early age-related maculopathy: a 6 month prospective study.

I C Frennesson 1, S E Nilsson 1
PMCID: PMC505291  PMID: 7488578

Abstract

AIM--To evaluate whether perifoveal laser photocoagulation of soft drusen reduces the total area occupied by drusen. METHOD--In a prospective, randomised study, 20 patients (mean age 71.3 (SD 7.7) years) with early age-related maculopathy (ARM) in the form of soft drusen and pigmentary changes and with good visual acuity (0.94 (0.09)) were treated with argon green laser photocoagulation. Mild laser burns (200 microns) were placed within a temporal horseshoe-shaped area, extending from a distance of no less than 500 microns from the centre of the fovea to the vascular arcades. They were placed on the drusen and scattered over areas where no drusen were present. Fundus colour photography and fluorescein angiography were performed at study entry as well as after 3 and 6 months. Nineteen age-matched patients (68.5 (6.2) years) with soft drusen maculopathy (visual acuity 0.95 (0.10)) were followed as a control group. Using a computer system, the area occupied by drusen was determined as a portion of the total area of a circle with a radius corresponding to 1250 microns in the fundus for the angiograms and 2500 microns for the colour photographs, respectively. At study entry, the mean area occupied by drusen in the treatment group was not significantly (p > 0.5-0.7) different from that of the control group. RESULTS--The mean drusen area of the angiograms and fundus colour photographs in the treated group decreased significantly from 19.3% to 13.8% (p = 0.002) and from 7.84% to 5.02% (p = 0.005), respectively. In the untreated group, the mean area occupied by drusen increased significantly from 17.4% to 20.4% (p = 0.030) and from 8.33% to 9.23% (p = 0.002), respectively. No significant changes in visual acuity (p > 0.05-0.5) or in visual fields (p > 0.05-0.3) occurred in either of the two groups during 6 months. CONCLUSION--The study suggests that the area occupied by soft drusen in patients with early ARM decreases after perifoveal laser photocoagulation but increases in an untreated control group.

Full text

PDF
905

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arden G. B., Berninger T., Hogg C. R., Perry S. A survey of color discrimination in German ophthalmologists. Changes associated with the use of lasers and operating microscopes. Ophthalmology. 1991 May;98(5):567–575. [PubMed] [Google Scholar]
  2. Arden G., Gündüz K., Perry S. Color vision testing with a computer graphics system: preliminary results. Doc Ophthalmol. 1988 Jun;69(2):167–174. doi: 10.1007/BF00153698. [DOI] [PubMed] [Google Scholar]
  3. Berninger T. A., Canning C. R., Gündüz K., Strong N., Arden G. B. Using argon laser blue light reduces ophthalmologists' color contrast sensitivity. Argon blue and surgeons' vision. Arch Ophthalmol. 1989 Oct;107(10):1453–1458. doi: 10.1001/archopht.1989.01070020527032. [DOI] [PubMed] [Google Scholar]
  4. Bressler N. M., Bressler S. B., Seddon J. M., Gragoudas E. S., Jacobson L. P. Drusen characteristics in patients with exudative versus non-exudative age-related macular degeneration. Retina. 1988;8(2):109–114. doi: 10.1097/00006982-198808020-00005. [DOI] [PubMed] [Google Scholar]
  5. Bressler S. B., Maguire M. G., Bressler N. M., Fine S. L. Relationship of drusen and abnormalities of the retinal pigment epithelium to the prognosis of neovascular macular degeneration. The Macular Photocoagulation Study Group. Arch Ophthalmol. 1990 Oct;108(10):1442–1447. doi: 10.1001/archopht.1990.01070120090035. [DOI] [PubMed] [Google Scholar]
  6. Figueroa M. S., Regueras A., Bertrand J. Laser photocoagulation to treat macular soft drusen in age-related macular degeneration. Retina. 1994;14(5):391–396. doi: 10.1097/00006982-199414050-00001. [DOI] [PubMed] [Google Scholar]
  7. Gass J. D. Drusen and disciform macular detachment and degeneration. Arch Ophthalmol. 1973 Sep;90(3):206–217. doi: 10.1001/archopht.1973.01000050208006. [DOI] [PubMed] [Google Scholar]
  8. Gregor Z., Bird A. C., Chisholm I. H. Senile disciform macular degeneration in the second eye. Br J Ophthalmol. 1977 Feb;61(2):141–147. doi: 10.1136/bjo.61.2.141. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Holz F. G., Wolfensberger T. J., Piguet B., Gross-Jendroska M., Wells J. A., Minassian D. C., Chisholm I. H., Bird A. C. Bilateral macular drusen in age-related macular degeneration. Prognosis and risk factors. Ophthalmology. 1994 Sep;101(9):1522–1528. doi: 10.1016/s0161-6420(94)31139-0. [DOI] [PubMed] [Google Scholar]
  10. Kahn H. A., Leibowitz H. M., Ganley J. P., Kini M. M., Colton T., Nickerson R. S., Dawber T. R. The Framingham Eye Study. I. Outline and major prevalence findings. Am J Epidemiol. 1977 Jul;106(1):17–32. doi: 10.1093/oxfordjournals.aje.a112428. [DOI] [PubMed] [Google Scholar]
  11. Klein B. E., Klein R. Cataracts and macular degeneration in older Americans. Arch Ophthalmol. 1982 Apr;100(4):571–573. doi: 10.1001/archopht.1982.01030030573002. [DOI] [PubMed] [Google Scholar]
  12. Klein R., Klein B. E., Linton K. L. Prevalence of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology. 1992 Jun;99(6):933–943. doi: 10.1016/s0161-6420(92)31871-8. [DOI] [PubMed] [Google Scholar]
  13. Klein R., Rowland M. L., Harris M. I. Racial/ethnic differences in age-related maculopathy. Third National Health and Nutrition Examination Survey. Ophthalmology. 1995 Mar;102(3):371–381. doi: 10.1016/s0161-6420(95)31012-3. [DOI] [PubMed] [Google Scholar]
  14. Leibowitz H. M., Krueger D. E., Maunder L. R., Milton R. C., Kini M. M., Kahn H. A., Nickerson R. J., Pool J., Colton T. L., Ganley J. P. The Framingham Eye Study monograph: An ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults, 1973-1975. Surv Ophthalmol. 1980 May-Jun;24(Suppl):335–610. [PubMed] [Google Scholar]
  15. Maltzman B. A., Mulvihill M. N., Greenbaum A. Senile macular degeneration and risk factors: a case-control study. Ann Ophthalmol. 1979 Aug;11(8):1197–1201. [PubMed] [Google Scholar]
  16. Marshall J. Interactions between sensory cells, glial cells and the retinal pigment epithelium and their response to photocoagulation. Dev Ophthalmol. 1981;2:308–317. doi: 10.1159/000395340. [DOI] [PubMed] [Google Scholar]
  17. Miller H., Miller B., Ryan S. J. The role of retinal pigment epithelium in the involution of subretinal neovascularization. Invest Ophthalmol Vis Sci. 1986 Nov;27(11):1644–1652. [PubMed] [Google Scholar]
  18. Moisseiev J., Alhalel A., Masuri R., Treister G. The impact of the macular photocoagulation study results on the treatment of exudative age-related macular degeneration. Arch Ophthalmol. 1995 Feb;113(2):185–189. doi: 10.1001/archopht.1995.01100020069031. [DOI] [PubMed] [Google Scholar]
  19. Sigelman J. Foveal drusen resorption one year after perifoveal laser photocoagulation. Ophthalmology. 1991 Sep;98(9):1379–1383. doi: 10.1016/s0161-6420(91)32122-5. [DOI] [PubMed] [Google Scholar]
  20. Smiddy W. E., Fine S. L. Prognosis of patients with bilateral macular drusen. Ophthalmology. 1984 Mar;91(3):271–277. doi: 10.1016/s0161-6420(84)34309-3. [DOI] [PubMed] [Google Scholar]
  21. Sperduto R. D., Hiller R. Systemic hypertension and age-related maculopathy in the Framingham Study. Arch Ophthalmol. 1986 Feb;104(2):216–219. doi: 10.1001/archopht.1986.01050140070022. [DOI] [PubMed] [Google Scholar]
  22. Vingerling J. R., Dielemans I., Hofman A., Grobbee D. E., Hijmering M., Kramer C. F., de Jong P. T. The prevalence of age-related maculopathy in the Rotterdam Study. Ophthalmology. 1995 Feb;102(2):205–210. doi: 10.1016/s0161-6420(95)31034-2. [DOI] [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES